Avoiding Electromagnetic Interference: FDA Issues Draft Guidance
This article was originally published in The Gray Sheet
The draft lists nine elements, including a summary of testing and results, that FDA wants to see from manufacturers to show new electrical devices pose no electromagnetic interference risk.
You may also be interested in...
In the final medical device electromagnetic compatibility guidance FDA clarified the scope of applications that could use this guidance and added a recommendation for sponsors to identify and consider the intended use environmental that could affect the EMC of their products.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.